Anti-SDE2/ C1orf55/ dJ671D7.1 monoclonal antibody

Anti-SDE2/ C1orf55/ dJ671D7.1 antibody for FACS & in-vivo assay

Target products collectionGo to SDE2/SDE2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2320-Ab-1/ GM-Tg-hg-MP2320-Ab-2Anti-Human SDE2 monoclonal antibodyHuman
GM-Tg-rg-MP2320-Ab-1/ GM-Tg-rg-MP2320-Ab-2Anti-Rat SDE2 monoclonal antibodyRat
GM-Tg-mg-MP2320-Ab-1/ GM-Tg-mg-MP2320-Ab-2Anti-Mouse SDE2 monoclonal antibodyMouse
GM-Tg-cynog-MP2320-Ab-1/ GM-Tg-cynog-MP2320-Ab-2Anti-Cynomolgus/ Rhesus macaque SDE2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2320-Ab-1/ GM-Tg-felg-MP2320-Ab-2Anti-Feline SDE2 monoclonal antibodyFeline
GM-Tg-cang-MP2320-Ab-1/ GM-Tg-cang-MP2320-Ab-2Anti-Canine SDE2 monoclonal antibodyCanine
GM-Tg-bovg-MP2320-Ab-1/ GM-Tg-bovg-MP2320-Ab-2Anti-Bovine SDE2 monoclonal antibodyBovine
GM-Tg-equg-MP2320-Ab-1/ GM-Tg-equg-MP2320-Ab-2Anti-Equine SDE2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2320-Ab-1/ GM-Tg-hg-MP2320-Ab-2; GM-Tg-rg-MP2320-Ab-1/ GM-Tg-rg-MP2320-Ab-2;
GM-Tg-mg-MP2320-Ab-1/ GM-Tg-mg-MP2320-Ab-2; GM-Tg-cynog-MP2320-Ab-1/ GM-Tg-cynog-MP2320-Ab-2;
GM-Tg-felg-MP2320-Ab-1/ GM-Tg-felg-MP2320-Ab-2; GM-Tg-cang-MP2320-Ab-1/ GM-Tg-cang-MP2320-Ab-2;
GM-Tg-bovg-MP2320-Ab-1/ GM-Tg-bovg-MP2320-Ab-2; GM-Tg-equg-MP2320-Ab-1/ GM-Tg-equg-MP2320-Ab-2
Products NameAnti-SDE2 monoclonal antibody
Formatmab
Target NameSDE2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SDE2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SDE2/ C1orf55/ dJ671D7.1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003713human SDE2 Lentivirus plasmid
    ORF Viral VectorvGMLP003713human SDE2 Lentivirus particle
    ORF Viral VectorpGMLPm003981mouse Sde2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003981mouse Sde2 Lentivirus particle


    Target information

    Target IDGM-MP2320
    Target NameSDE2
    Gene ID163859,208768,289315,700761,480111,101086529,534664,100054411
    Gene Symbol and SynonymsC16H1orf55,C1orf55,C7H1orf55,dJ671D7.1,RGD1305572,SDE2
    Uniprot AccessionQ6IQ49,Q5BJN8
    Uniprot Entry NameSDE2_HUMAN,SDE2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000143751
    Target ClassificationN/A

    The target: SDE2, gene name: SDE2, also named as C1orf55, dJ671D7.1. Enables damaged DNA binding activity. Involved in several processes, including cellular response to UV; mitotic G1 DNA damage checkpoint signaling; and protein ubiquitination. Located in several cellular components, including Golgi apparatus; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.